NFKB1 and neoplasm: HRS cells express CD30, CD40, TACI, BCMA, and RANK, all of which can induce the NF-κB activity [15,16,17,18], and there is evidence that the tumour microenvironment of cHL can contribute to the activation of these receptors [19,20].